|
|
Volumn 8, Issue 11, 1999, Pages 1917-1927
|
|
Update on clinical trials in the treatment of pulmonary disease in patients with cystic fibrosis
|
|
Author keywords
Clinical trials; Cystic fibrosis; Pulmonary disease
|
|
Indexed keywords
8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE;
ALPHA 1 ANTITRYPSIN;
AMILORIDE;
ANTIINFLAMMATORY AGENT;
ARYLBUTYRIC ACID DERIVATIVE;
CE 1037;
DEXTRAN;
DORNASE ALFA;
FK 706;
GELSOLIN;
LUNG SURFACTANT;
MANNITOL;
N [1 (1,3 BENZODIOXOL 5 YL)BUTYL] 3,3 DIETHYL 2 [4 [(4 METHYL 1 PIPERAZINYL)CARBONYL]PHENOXY] 4 OXO 1 AZETIDINECARBOXAMIDE;
NACYSTELYN;
PENTOXIFYLLINE;
PROTEINASE INHIBITOR;
PSEUDOMONAS ANTIBODY;
PSEUDOSTAT;
RBPI 21;
SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;
SODIUM CHANNEL BLOCKING AGENT;
TOBRAMYCIN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
TYLOXAPOL;
UNCLASSIFIED DRUG;
CYSTIC FIBROSIS;
GENE THERAPY;
HOST RESISTANCE;
HUMAN;
INFECTION SENSITIVITY;
ION TRANSPORT;
LUNG DISEASE;
PROTEIN EXPRESSION;
REVIEW;
SECRETIONS;
|
|
EID: 0032726174
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.11.1917 Document Type: Review |
|
Times cited : (4)
|
|
References (62)
|
